Literature DB >> 19644638

No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families.

H Yue1, J-W He, H Zhang, W-W Hu, Y-Q Hu, M Li, Y-J Liu, S-H Wu, Z-L Zhang.   

Abstract

UNLABELLED: Association between SNPs in polymorphism in peroxisome [corrected] proliferator-activated receptor-gamma (PPARG) and peak bone mineral density (BMD) variation of women was measured in 401 Chinese nuclear families using quantitative transmission disequilibrium test (QTDT). The peak BMD variation was not attributable to PPARG in our sample.
INTRODUCTION: The purpose of this study is to test whether genetic PPARG might play a role in normal variation in peak BMD.
METHODS: We genotyped 10 tagging SNPs in PPARG using allele-specific polymerase chain reaction and further test whether these SNPs were associated with peak BMD variation at the lumbar spine and femoral neck of women in 401 Chinese nuclear families using QTDT. Furthermore, the association between these SNPs in PPARG and BMD in 710 postmenopausal Chinese women was measured.
RESULTS: Using QTDT for within-family association, we failed to find that single SNP and haplotype were significantly associated with peak BMD at the lumbar spine and femoral neck. Meanwhile, we found that only rs1801282 was significantly associated with BMD at the lumbar spine in postmenopausal women (P = 0.013).
CONCLUSIONS: Our present results suggest, for the first time, that the genetic polymorphism in PPARG is not a major contributor to the observed variability in peak BMD at the lumbar spine and femoral neck in Chinese women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644638     DOI: 10.1007/s00198-009-1028-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  33 in total

1.  A general test of association for quantitative traits in nuclear families.

Authors:  G R Abecasis; L R Cardon; W O Cookson
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families.

Authors:  Zhen-lin Zhang; Jin-wei He; Yue-juan Qin; Yun-qiu Hu; Miao Li; Yu-juan Liu; Hao Zhang; Wei-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2007-02       Impact factor: 6.150

3.  Changes in axial bone density with age: a twin study.

Authors:  P J Kelly; T Nguyen; J Hopper; N Pocock; P Sambrook; J Eisman
Journal:  J Bone Miner Res       Date:  1993-01       Impact factor: 6.741

4.  Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men.

Authors:  Munro Peacock; Daniel L Koller; Tonya Fishburn; Subha Krishnan; Dongbing Lai; Siu Hui; C Conrad Johnston; Tatiana Foroud; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

5.  No evidence for linkage and/or association of human alpha2-HS glycoprotein gene with bone mineral density variation in Chinese nuclear families.

Authors:  X H Liu; Y J Liu; D K Jiang; Y M Li; M X Li; Y J Qin; W X Jian; Q Zhou; H W Deng
Journal:  Calcif Tissue Int       Date:  2003-09       Impact factor: 4.333

6.  PPARG by dietary fat interaction influences bone mass in mice and humans.

Authors:  Cheryl L Ackert-Bicknell; Serkalem Demissie; Caralina Marín de Evsikova; Yi-Hsiang Hsu; Victoria E DeMambro; David Karasik; L Adrienne Cupples; Jose M Ordovas; Katherine L Tucker; Kelly Cho; Ernesto Canalis; Beverly Paigen; Gary A Churchill; Jiri Forejt; Wesley G Beamer; Serge Ferrari; Mary L Bouxsein; Douglas P Kiel; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

7.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

8.  Fat's loss is bone's gain.

Authors:  Liming Pei; Peter Tontonoz
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

9.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  The Genetics of PPARG and the Skeleton.

Authors:  Cheryl Ackert-Bicknell; Clifford Rosen
Journal:  PPAR Res       Date:  2006       Impact factor: 4.964

View more
  8 in total

1.  Identification of pleiotropic genetic variants affecting osteoporosis risk in a Korean elderly cohort.

Authors:  Eun Pyo Hong; Ka Hyun Rhee; Dong Hyun Kim; Ji Wan Park
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

2.  Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men.

Authors:  Jin-Wei He; Hua Yue; Wei-Wei Hu; Yun-Qiu Hu; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2011-01-08       Impact factor: 2.626

3.  Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families.

Authors:  W-J Xiao; Y-H Ke; J-W He; H Zhang; J-B Yu; W-W Hu; J-M Gu; G Gao; H Yue; C Wang; Y-Q Hu; M Li; Y-J Liu; W-Z Fu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2011-11-17       Impact factor: 4.507

4.  Association between SNPs and haplotypes in the METTL21C gene and peak bone mineral density and body composition in Chinese male nuclear families.

Authors:  Fei Zhao; Li-Hong Gao; Shan-Shan Li; Zhan-Ying Wei; Wen-Zhen Fu; Jin-Wei He; Yu-Juan Liu; Yun-Qiu Hu; Jing Dong; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2016-09-14       Impact factor: 2.626

5.  Genotyping of peroxisome proliferator-activated receptor gamma (PPAR-γ) polymorphism (Pro12Ala) in Iranian population.

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

6.  Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala).

Authors:  Fatemeh Namvaran; Parvaneh Rahimi-Moghaddam; Negar Azarpira; Mohammad Hossien Dabbaghmanesh; Marzieh Bakhshayeshkaram; Mohamad Mahdi Namvaran
Journal:  J Res Med Sci       Date:  2013-04       Impact factor: 1.852

7.  LGR4 Gene Polymorphisms Are Associated With Bone and Obesity Phenotypes in Chinese Female Nuclear Families.

Authors:  Su-Qin Shi; Shan-Shan Li; Xiao-Ya Zhang; Zhe Wei; Wen-Zhen Fu; Jin-Wei He; Yun-Qiu Hu; Miao Li; Li-Li Zheng; Zhen-Lin Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-11       Impact factor: 5.555

8.  Association between LGR4 polymorphisms and peak bone mineral density and body composition.

Authors:  Wei-Jia Yu; Zeng Zhang; Wen-Zhen Fu; Jin-Wei He; Chun Wang; Zhen-Lin Zhang
Journal:  J Bone Miner Metab       Date:  2020-05-12       Impact factor: 2.626

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.